AKT1 and breast carcinoma: Here, using chemoresistant breast cancer cell models, we show that miR-205 targets VEGFA as well as FGF2 mRNA 3′-UTR and represses their expression, leading to impaired PI3K/AKT signaling and increased apoptosis both in vitro and in vivo.